Voyager Therapeutics
$17.199876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$17.19
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$0.22 (1.30%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours
Why Robinhood?
You can buy or sell VYGR and other stocks, options, ETFs, and crypto commission-free!
About VYGR
Voyager Therapeutics, Inc. operates as a clinical-stage gene therapy company, which develops treatments for patients suffering from central nervous system. Its pipeline of gene theraphy programs include VY-AADC, VY-SOD101, VY-HTT01, VY-FXN01, Tau Program, and VY-NAV01. Read More The company was founded by Guangping Gao, Mark A. Kay, Krystof Bankiewicz and Phillip Zamore in June 2013 and is headquartered in Cambridge, MA.
Employees
123
Headquarters
Cambridge, Massachusetts
Founded
2013
Market Cap
634.90M
Price-Earnings Ratio
—
Dividend Yield
0.00
Average Volume
391.11K
High Today
$17.39
Low Today
$16.81
Open Price
$17.17
Volume
395.75K
52 Week High
$28.79
52 Week Low
$7.76
Collections
Price Paid on Robinhood
4% Higher
Right Now
52 Week Low
$7.76
Average Price Paid
$16.53
52 Week High
$24.24
Analyst Ratings
77%
of 13 ratings
Buy
77%
Hold
23%
Sell
0%
VYGR Earnings
-$0.81
-$0.35
$0.12
$0.58
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Estimated
—
Actual
Expected Nov 6, Pre-Market